Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Analysts at Leerink Partnrs upped their Q1 2025 EPS estimates for Edgewise Therapeutics in a research note issued on Wednesday, April 2nd. Le… [+5266 chars]...
Read morePiper Sandler reaffirmed their overweight rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently h… [+5016 chars]...
Read moreWe recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against othe… [+147 chars]...
Read moreKLP Kapitalforvaltning AS purchased a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 6,800 shares of the … [+5301 chars]...
Read moreOrion Portfolio Solutions LLC decreased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 8.3% during the 4th quarter, Holdings Channel.com reports. The fund owned … [+5407 chars]...
Read moreCorebridge Financial Inc. lowered its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 7.0% in the fourth quarter, according to the company in its most recent Form 13F… [+5792 chars]...
Read more